SCHEMBL5455142

SCHEMBL5455142

O=C(O)c1ccccc1Cc1ccccc1Cl

nearest known ligand 0.61

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.61
TP53 P04637 1/20 0.58
HTT P42858 1/20 0.58
TSHR P16473 2/20 0.56
FOLH1 Q04609 1/20 0.52
MEN1 O00255 1/20 0.51
KMT2A Q03164 1/20 0.51
CYP2C9 P11712 1/20 0.50
HIF1A Q16665 1/20 0.50
L3MBTL1 Q9Y468 1/20 0.50
SLC16A3 O15427 2/20 0.49
MRGPRX4 Q96LA9 1/20 0.49
ALOX15 P16050 1/20 0.48
NPC1 O15118 2/20 0.47
RAB9A P51151 2/20 0.47
CES2 O00748 1/20 0.47
CES1 P23141 1/20 0.47
NR4A2 P43354 2/20 0.46
CTBP2 P56545 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL69352 0.88 TSHR (0.68) ALDH1A1TP53HTTTSHRFOLH1
SCHEMBL11327561 0.86 HMGB1 (0.54) ALDH1A1TP53HTTTSHRMEN1
SCHEMBL17938486 0.86 TSHR (0.66) ALDH1A1TP53HTTTSHRFOLH1
SCHEMBL27930791 0.85 ALDH1A1 (0.57) ALDH1A1TP53HTTTSHRFOLH1
SCHEMBL11115984 0.85 FOLH1 (0.61) ALDH1A1TP53HTTTSHRFOLH1
SCHEMBL11548850 0.84 ALDH1A1 (0.52) ALDH1A1TP53HTTTSHRMEN1
SCHEMBL4351346 0.83 TP53 (0.50) ALDH1A1TP53HTTTSHRMEN1
SCHEMBL3461538 0.83 LMNA (0.50) ALDH1A1KMT2AL3MBTL1NPC1RAB9A
SCHEMBL9396653 0.82 TSHR (0.58) ALDH1A1TP53HTTTSHRFOLH1
SCHEMBL10386798 0.82 ALDH1A1 (0.49) ALDH1A1TP53HTTTSHRMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070082922-A1 Huperzine a prodrugs and uses thereof PAN BAI-CHUAN 2007-04-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070082922-A1 Huperzine a prodrugs and uses thereof APP, ACHE, PSEN1 ALDH1A1 312/4885TP53 2620/4885HTT 33/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.